Literature DB >> 8248541

Autoradiographic distribution of putative muscarinic receptor sub-types in mammalian brain.

R Quirion1, I Aubert, D M Araujo, A Hersi, P Gaudreau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248541     DOI: 10.1016/s0079-6123(08)62384-5

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  6 in total

1.  Axotomy-induced loss of m2 muscarinic receptor mRNA in the rat facial motor nucleus precedes a decrease in concentration of muscarinic receptors.

Authors:  D B Hoover; R H Baisden; J V Lewis
Journal:  Histochem J       Date:  1996-11

2.  Effects of acetylcholine on coding of taste information in the primary gustatory cortex in rats.

Authors:  Kayoko Hasegawa; Hisashi Ogawa
Journal:  Exp Brain Res       Date:  2006-11-16       Impact factor: 1.972

Review 3.  Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.

Authors:  R Quirion
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

4.  Changes in acetylcholinesterase activity and muscarinic receptor bindings in mu-opioid receptor knockout mice.

Authors:  Lu-Tai Tien; Lir-Wan Fan; Chiharu Sogawa; Tangeng Ma; Horance H Loh; Ing-Kang Ho
Journal:  Brain Res Mol Brain Res       Date:  2004-07-05

5.  In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter.

Authors:  Izumi Uno; Takashi Kozaka; Daisuke Miwa; Yoji Kitamura; Mohammad Anwar-Ul Azim; Kazuma Ogawa; Junichi Taki; Seigo Kinuya; Kazuhiro Shiba
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 6.  In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents.

Authors:  Kazuma Ogawa; Kazuhiro Shiba
Journal:  Contrast Media Mol Imaging       Date:  2018-06-13       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.